Toxicity of high-dose sequential chemotherapy and purged autologous hematopoietic cell transplantation precludes its use in refractory/recurrent non-Hodgkin's lymphoma. [electronic resource]
Producer: 20010308Description: 555-62 p. digitalISSN:- 1083-8791
- Acute Kidney Injury -- chemically induced
- Adult
- Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
- Bone Marrow Diseases -- chemically induced
- Bone Marrow Purging
- Cardiomyopathies -- chemically induced
- Chemical and Drug Induced Liver Injury -- etiology
- Combined Modality Therapy
- Cyclophosphamide -- administration & dosage
- Cystitis -- chemically induced
- Disease Progression
- Disease-Free Survival
- Drug Administration Schedule
- Etoposide -- administration & dosage
- Female
- Follow-Up Studies
- Granulocyte Colony-Stimulating Factor -- therapeutic use
- Hematopoietic Stem Cell Mobilization -- adverse effects
- Hematopoietic Stem Cell Transplantation -- adverse effects
- Hemorrhage -- chemically induced
- Humans
- Infections
- Leucovorin -- administration & dosage
- Life Tables
- Lymphoma, Non-Hodgkin -- drug therapy
- Male
- Melphalan -- administration & dosage
- Methotrexate -- administration & dosage
- Middle Aged
- Mitoxantrone -- administration & dosage
- Pilot Projects
- Salvage Therapy
- Survival Analysis
- Survival Rate
- Transplantation Conditioning -- adverse effects
- Transplantation, Autologous
- Treatment Outcome
- Vincristine -- administration & dosage
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.